Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancerYue Zeng, Fang Wu, Wenjie Xiao et al.|Nature Medicine|2024Cited by 116
Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer TreatmentsWentao Tian, Fang Wu, Yi Liu et al.|Frontiers in Cell and Developmental Biology|2021Cited by 78
Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancersChunhong Hu, Fang Wu, Lishu Zhao et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 77
The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancerYue Pan, Fang Wu, Yucheng Fu et al.|Biomarker Research|2022Cited by 57
Efficacy and safety of first-line immune checkpoint inhibitors combined with chemotherapy for extensive-stage small cell lung cancer: A network meta-analysisShuxing Wang, Fang Wu, Yunshu Li et al.|Lung Cancer|2023Cited by 29